IL18 and Hepatic fibrosis: However, one study contradicts our results; in this report, cilengitide failed to have antifibrotic effects on both thioacetamide (TAA) and bile duct ligation (BDL) models of hepatic fibrosis, but markedly increased collagen deposition and upregulated the expression of inflammatory genes, including TNFα and IL18.29